Literature DB >> 2987530

Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I.

L Ratner, S F Josephs, B Starcich, B Hahn, G M Shaw, R C Gallo, F Wong-Staal.   

Abstract

A variant of human T-cell leukemia virus subgroup I (HTLV-I), designated HTLV-Ib, has been isolated from a transformed T-lymphocytic cell line established from a Zairian patient with adult T-cell lymphoma. A recombinant phage clone of the variant provirus, denoted lambda MC-1, hybridizes under high stringency to HTLV-I DNA probes, but 17 of 43 restriction enzyme sites differ from those of HTLV-I, 10 of them clustering within 1.5 kilobases in the env-pX region. Since this variant virus retains its capacity to transform T-cells in vitro, and since a pX product is suspected to be important in transformation, we have determined the nucleotide sequence of the entire pX region of this virus for comparison to the prototype HTLV-I. In addition, the region between the gag and pol genes, parts of the pol and env genes, and a portion of the U3 region of the long terminal repeat sequence were also analyzed. We noted 141 single-base-pair changes among 3,897 base pairs, which were relatively well distributed over those portions of the provirus that were examined. In addition, an 11-base-pair deletion was found which included the potential initiator ATG codon of the first open reading frame of pX (pX-I). The next potential initiator codon predicted by the sequence is followed by 10 codons and then a termination codon. An identical deletion was also demonstrated in the only provirus present in another cell line established from the same patient on a different occasion after transformation in vitro of normal human umbilical cord blood cells. These results indicate that pX-I is not required for transformation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987530      PMCID: PMC254865     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Recombinant avian oncoviruses. II. Alterations in the gag proteins and evidence for intragenic recombination.

Authors:  R Shaikh; M Linial; S Brown; A Sen; R Eisenman
Journal:  Virology       Date:  1979-01-30       Impact factor: 3.616

2.  Structural protein markers in the avian oncoviruses.

Authors:  C W Rettenmier; H Hanafusa
Journal:  J Virol       Date:  1977-12       Impact factor: 5.103

3.  Recombinant avian oncoviruses. I. Alterations in the precursor to the internal structural proteins.

Authors:  R Shaikh; M Linial; J Coffin; R Eisenman
Journal:  Virology       Date:  1978-06-15       Impact factor: 3.616

4.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

5.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

6.  Human T lymphocyte cell line producing colony-stimulating activity.

Authors:  D W Golde; S G Quan; M J Cline
Journal:  Blood       Date:  1978-11       Impact factor: 22.113

7.  Subgroup-specific antigenic determinants of avian RNA tumor virls structural proteins: analysis of virus recombinants.

Authors:  M J Hayman; P K Vogt
Journal:  Virology       Date:  1976-09       Impact factor: 3.616

8.  Variation in avian retrovirus genomes.

Authors:  J M Coffin; P N Tsichlis; C S Barker; S Voynow; H L Robinson
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

9.  Retroviruses as mutagens: insertion and excision of a nontransforming provirus alter expression of a resident transforming provirus.

Authors:  H E Varmus; N Quintrell; S Ortiz
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

10.  Transformation-defective mutants of feline sarcoma virus which express a product of the viral src gene.

Authors:  L Donner; L P Turek; S K Ruscetti; L A Fedele; C J Sherr
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

View more
  20 in total

1.  Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization.

Authors:  J T Kimata; L Ratner
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

Review 2.  Oligonucleotide treatment of ras-induced tumors in nude mice.

Authors:  E Wickstrom
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

3.  Robustness of maximum likelihood tree estimation against different patterns of base substitutions.

Authors:  K Fukami-Kobayashi; Y Tateno
Journal:  J Mol Evol       Date:  1991-01       Impact factor: 2.395

4.  Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes.

Authors:  M D Robek; F H Wong; L Ratner
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Processing of gag precursor polyprotein of human T-cell leukemia virus type I by virus-encoded protease.

Authors:  S H Nam; M Kidokoro; H Shida; M Hatanaka
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

6.  Translation of gag, pro, and pol gene products of human T-cell leukemia virus type 2.

Authors:  N Mador; A Panet; A Honigman
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.

Authors:  J Arp; M LeVatte; J Rowe; S Perkins; E King; C Leystra-Lantz; S K Foung; G A Dekaban
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  Two major subgroups of human T-cell leukemia virus-1 in Japan.

Authors:  H Siomi; T Nosaka; T Saida; H Miwa; Y Hinuma; S Shirakawa; N Miyamoto; T Kondo; K Araki; M Ichimaru
Journal:  Virus Genes       Date:  1988-07       Impact factor: 2.332

9.  Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations.

Authors:  A Gessain; R C Gallo; G Franchini
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis.

Authors:  S Niewiesk; S Daenke; C E Parker; G Taylor; J Weber; S Nightingale; C R Bangham
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.